More importantly, treatment of cancer cells with an anti-HER3 monoclonal antibody (HER3Mab) effectively neutralized the elevated pHER3 and pAKT levels induced by NRG-1 in high DJ-1 expressing and control (pCDNA) cancer cells (Figure 5A). The gene discussed is PARK7; the disease is cancer.